Nephrostomy Devices Market Forecasts to 2030 – Global Analysis By Product Type (Nephrostomy, Catheters, Guidewires, Dilators Sheaths, Drainage Tubes and Other Product Types), End User (Ambulatory Surgical Centers, Emergency Clinics, Hospitals and Other En

Nephrostomy Devices Market Forecasts to 2030 – Global Analysis By Product Type (Nephrostomy, Catheters, Guidewires, Dilators Sheaths, Drainage Tubes and Other Product Types), End User (Ambulatory Surgical Centers, Emergency Clinics, Hospitals and Other End Users), and By Geography

According to Stratistics MRC, the Global Nephrostomy Devices Market is accounted for $1500.5 million in 2023 and is expected to reach $2887.1 million by 2030 growing at a CAGR of 9.8% during the forecast period. To drain urine from the kidney, a thin, flexible tube called a nephrostomy tube is inserted through the skin. The tube is utilized to temporarily discharge obstructed pee. A plastic bag is connected to the tube outside the body to collect the fluid. Nephrostomies can help keep the kidneys healthy and shield them from injury and infection. A nephrostomy device can also aid in the diagnosis of an underlying issue since the ureter can be seen using ultrasonography, X-rays, and contrast material injection.

According to the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life.

Market Dynamics:

Driver:

Rising incidence of urological disorders

Increased incidence of urological conditions such as hydronephrosis, kidney stones, urine retention, bladder cancer, and prostate cancer and the rise in percutaneous nephrostomy treatments are the main factors impacting the market throughout the projected period. Furthermore, the geriatric population is more susceptible to chronic illnesses that need long-term care, such as incontinence, digestive difficulties, and chronic ailments. Therefore, a high-impact driver is anticipated to be an increase in the world's senior population. Additionally, the number of urological procedures performed will climb along with the aging population, which drives market growth.

Restraint:

Entailing negative outcomes

One frequent concern is infection at the location where the nephrostomy tube is placed. Healthcare professionals take preventative measures to reduce this risk, including employing sterile procedures during the treatment and giving patients the right care and maintenance instructions. During or after the nephrostomy surgery, bleeding is possible, which can happen in exceptional circumstances and call for additional medical attention. Some individuals may experience an allergic response to the components of the dressing or nephrostomy tube. There may be slight bleeding, discomfort, or pain at the removal site when the nephrostomy tube is no longer required, thus hampering the growth of the market.

Opportunity:

Rise in demand for minimal invasive operations

Over the course of the forecast period, factors like a rise in demand for less invasive operations and technical developments in nephrostomy devices with a high success rate will drive the market. For patients experiencing pain due to kidney obstruction or infections, a nephrostomy can provide significant pain relief by alleviating the pressure and reducing inflammation in the kidney. It also allows the kidney to continue filtering waste and maintaining fluid balance, creating a wide range of opportunities for market growth.

Threat:

Availability of alternative procedures

The availability of alternatives to nephrostomy surgery can affect patient care in both positive and negative ways, as different procedures may be chosen without a careful assessment of the patient's needs and medical condition, which carries both potential risks for their care. This may result in the decision to take an unsuitable course of action, which may provide less than ideal results or cause difficulties. Various factors, including the experience of the healthcare professional and the accessibility of resources, can have a significant impact on the quality of alternative operations.

Covid-19 Impact

The initial wave of COVID-19 had a substantial influence on the market for nephrostomy devices because of the delays in nephrology-related procedures and consultations brought on by the global lockdown. The COVID-19 outbreak forced urology departments worldwide to restructure care owing to insufficient resources and manpower. However, as the regulations are loosened, the market is anticipated to expand in the years to come as a result of the rise in renal disorders and the increased use of nephrostomy devices.

The guidewires segment is expected to be the largest during the forecast period

The guidewires segment is estimated to have significant growth because of its ability to gain access and aid transit across different luminal structures. A guidewire is an effective instrument. To make the placement of endourological tools during diagnostic or interventional procedures easier, urological guidewires are used. Due to the rise in renal issues and the desire for minimally invasive kidney disease manufacturers, the rising incidence of kidney stone disorders, the frequency of ovarian, bladder, and prostate malignancies, and the rising desire for less invasive surgical treatments are anticipated to raise the need for guidewires during nephrostomy procedures, which is predicted to encourage market expansion.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgical centers segment is anticipated to witness the highest CAGR during the forecast period, as they provide more individualized services and greater results in comparison to hospitals and other healthcare settings. Additionally, ASCs do not have to deal with the issue of treating a variety of diseases and disorders; they can guarantee that patients receive tailored attention with a better patient experience, thus enhancing the growth of the market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the advantageous reimbursement rules, rising product awareness, the availability of highly qualified physicians, and the existence of established healthcare facilities in the area. In addition to the rapid use of technologically improved medical goods, the rise in the prevalence of kidney stones in the region is expected to increase the demand for nephrostomy devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the establishment of medical facilities such as hospitals, clinics, and urology specialty centers. This raises the need for nephrostomy devices by making healthcare services more accessible to those who need nephrostomy surgeries. Additionally, regional governments are enacting laws and launching efforts to upgrade the healthcare system and promote the use of cutting-edge medical technologies. This covers reimbursement plans and financial aid for urological procedures, thus propelling the growth of the market.

Key players in the market

Some of the key players profiled in the Nephrostomy Devices Market include Angiodynamics Inc, Argon Medical, B. Braun Melsungen AG., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Group (Cook Medical Incorporated), Envaste Limited, Medi-Globe GmbH, Meditech Devices Pvt Ltd, Olympus Corporation, Straub Medical AG, SURU International Pvt. Ltd, Teleflex Incorporated and Uresil LLC

Key Developments:

In August 2023, Cardinal health launches next generation medical device to improve neonatal feeding, through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills.

In June 2023, Becton, Dickinson and Company a leading global medical technology company, announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS for $540 million.

In May 2023, Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument. The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue sample.

Product Types Covered:
• Nephrostomy Catheters
• Guidewires
• Dilators Sheaths
• Drainage Tubes
• Other Product Types

End Users Covered:
• Ambulatory Surgical Centers
• Emergency Clinics
• Hospitals
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Companies Mentioned
Angiodynamics Inc
Argon Medical
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corporation
Cardinal Health
Coloplast Group
Cook Group (Cook Medical Incorporated)
Envaste Limited
Medi-Globe GmbH
Meditech Devices Pvt Ltd
Olympus Corporation
Straub Medical AG
SURU International Pvt. Ltd
Teleflex Incorporated
Uresil LLC